Pinnacle Financial Partners Inc Eli Lilly & CO Transaction History

Pinnacle Financial Partners Inc

  • $4.59 Billion
  • Q1 2024

A detailed history of Pinnacle Financial Partners Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Pinnacle Financial Partners Inc holds 41,160 shares of LLY stock, worth $37 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
41,160
Previous 37,540 9.64%
Holding current value
$37 Million
Previous $21.9 Million 46.33%
% of portfolio
0.7%
Previous 0.52%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024
BUY
$592.2 - $792.28 $2.14 Million - $2.87 Million
3,620 Added 9.64%
41,160 $32 Million
Q4 2023

Jan 22, 2024
SELL
$525.19 - $619.13 $379,712 - $447,630
-723 Reduced 1.89%
37,540 $21.9 Million
Q3 2023

Nov 03, 2023
SELL
$434.7 - $599.3 $1.3 Million - $1.79 Million
-2,988 Reduced 7.24%
38,263 $20.6 Million
Q2 2023

Aug 07, 2023
SELL
$350.74 - $468.98 $1.36 Million - $1.82 Million
-3,872 Reduced 8.58%
41,251 $19.3 Million
Q1 2023

Apr 26, 2023
BUY
$310.63 - $364.82 $63,368 - $74,423
204 Added 0.45%
45,123 $15.5 Million
Q4 2022

Feb 03, 2023
BUY
$321.55 - $374.67 $7,395 - $8,617
23 Added 0.05%
44,919 $16.4 Million
Q3 2022

Oct 31, 2022
SELL
$296.48 - $337.87 $62,853 - $71,628
-212 Reduced 0.47%
44,896 $14.5 Million
Q2 2022

Jul 29, 2022
BUY
$278.73 - $327.27 $351,757 - $413,014
1,262 Added 2.88%
45,108 $14.6 Million
Q1 2022

May 02, 2022
SELL
$234.69 - $291.66 $851,220 - $1.06 Million
-3,627 Reduced 7.64%
43,846 $12.6 Million
Q4 2021

Feb 01, 2022
BUY
$224.85 - $279.04 $70,602 - $87,618
314 Added 0.67%
47,473 $13.1 Million
Q3 2021

Oct 26, 2021
BUY
$221.6 - $272.71 $62,712 - $77,176
283 Added 0.6%
47,159 $10.9 Million
Q2 2021

Jul 21, 2021
SELL
$180.55 - $233.54 $82,872 - $107,194
-459 Reduced 0.97%
46,876 $10.8 Million
Q1 2021

Apr 19, 2021
SELL
$164.32 - $212.72 $3.99 Million - $5.17 Million
-24,309 Reduced 33.93%
47,335 $8.84 Million
Q4 2020

Jan 13, 2021
SELL
$130.46 - $172.63 $264,051 - $349,403
-2,024 Reduced 2.75%
71,644 $12.1 Million
Q3 2020

Oct 27, 2020
BUY
$146.22 - $169.13 $249,597 - $288,704
1,707 Added 2.37%
73,668 $10.9 Million
Q2 2020

Jul 28, 2020
BUY
$136.42 - $164.18 $383,203 - $461,181
2,809 Added 4.06%
71,961 $11.8 Million
Q1 2020

Apr 16, 2020
BUY
$119.05 - $147.35 $1.35 Million - $1.68 Million
11,374 Added 19.69%
69,152 $9.59 Million
Q4 2019

Feb 06, 2020
BUY
$106.92 - $132.43 $14,754 - $18,275
138 Added 0.24%
57,778 $7.59 Million
Q3 2019

Oct 25, 2019
BUY
$106.79 - $116.16 $641,167 - $697,424
6,004 Added 11.63%
57,640 $6.45 Million
Q2 2019

Aug 13, 2019
BUY
$110.79 - $129.32 $334,364 - $390,287
3,018 Added 6.21%
51,636 $5.72 Million
Q1 2019

May 02, 2019
BUY
$111.31 - $131.02 $249,223 - $293,353
2,239 Added 4.83%
48,618 $6.31 Million
Q4 2018

Feb 04, 2019
BUY
$105.9 - $118.64 $95,627 - $107,131
903 Added 1.99%
46,379 $5.37 Million
Q3 2018

Oct 31, 2018
BUY
$85.86 - $107.31 $48,596 - $60,737
566 Added 1.26%
45,476 $4.88 Million
Q2 2018

Jul 27, 2018
BUY
$75.7 - $86.88 $194,246 - $222,934
2,566 Added 6.06%
44,910 $3.83 Million
Q1 2018

May 03, 2018
BUY
$74.21 - $87.6 $37,105 - $43,800
500 Added 1.19%
42,344 $3.28 Million
Q4 2017

Feb 08, 2018
BUY
$81.94 - $87.89 $390,116 - $418,444
4,761 Added 12.84%
41,844 $3.53 Million
Q3 2017

Nov 08, 2017
BUY
$77.07 - $85.54 $2.86 Million - $3.17 Million
37,083
37,083 $3.17 Million

Others Institutions Holding LLY

# of Institutions
3,722
Shares Held
738M
Call Options Held
7.09M
Put Options Held
7.24M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $853B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Pinnacle Financial Partners Inc Portfolio

Follow Pinnacle Financial Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinnacle Financial Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pinnacle Financial Partners Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email